THE draft report on the post-market review of chronic obstructive pulmonary disease (COPD) medicines has released, with the Health Department now seeking input from stakeholders.
With the large number of products now indicated for the treatment of COPD, there is a concern that multiple items may be used inappropriately.
Submission details: pbs.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 May 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 May 17
